The Effects of Acute Erythropoietin on Hepcidin and Dietary Iron Absorption Following Military-relevant Exercise in Energy Deficit: Pilot Study
Running, not enrolling · Not applicable · Has a placebo group
Conditions studied: Iron Absorption
In brief
Military personnel frequently experience declines in iron status during training and when in the field, which may compromise performance. The overall purpose of this study is to determine why the decline in iron status occurs and potential countermeasures. Participants will be given an acute dose of erythropoietin (EPO) or placebo and will complete a 90-minute load carriage exercise test. Prior to the main trial, this pilot study will determine the optimal approach to assess iron absorption following exercise (red blood cell incorporation or plasma isotope appearance), the percentage of iron incorporated into red blood cells with EPO compared to placebo, and the timing of the intervention.
Key facts
- Study ID
- NCT07517562
- Run by
- Pennington Biomedical Research Center
- People needed
- 6
- Starts
- 2025-09-01
- Expected to finish
- 2026-05-01
- Last updated by the study team
- 2026-04-08
Who can join
Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Males and premenopausal females ages 18-45 years
- Physically active
You may not qualify if…
- Low iron stores (ferritin <15 mg/mL)
- Anemia (females: hemoglobin < 12 g/dL, males: hemoglobin < 13 g/dL)
Where it is running
- LSU Pennington Biomedical Research Center — Baton Rouge, Louisiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.